Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03901469
Title A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zenith Epigenetics

triple-receptor negative breast cancer


Talazoparib + ZEN-3694

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.